OAC
TNYA icon

OMERS Administration Corp’s Tenaya Therapeutics TNYA Stock Holding History

OMERS Administration Corp’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$143K Sell
207,100
-29,300
-12% -$21.6K ﹤0.01% 968
2025
Q4 		$168K Buy
+236,400
New +$322K ﹤0.01% 931

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OMERS Administration Corp's TNYA Position: Q1 2026 in Review

OMERS Administration Corp reduced its Tenaya Therapeutics (TNYA) stake by 12% in Q1 2026, selling an estimated $21.6K and leaving 207,100 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #968.

OMERS Administration Corp first reported a position in TNYA in Q4 2025 and has held it in 2 quarters since. The position peaked at $168K in Q4 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • OMERS Administration Corp held 207,100 shares of Tenaya Therapeutics worth $143K as of Q1 2026.
  • OMERS Administration Corp sold 29,300 Tenaya Therapeutics shares in Q1 2026, an estimated $21.6K.
  • Tenaya Therapeutics made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #968 holding.
  • OMERS Administration Corp first reported a position in Tenaya Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • OMERS Administration Corp's Tenaya Therapeutics position peaked at $168K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.